| Glenmark Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532296 |
NSE Symbol : GLENMARK |
P/E(TTM) : 28.81 |
|
ISIN Demat : INE935A01035 |
Div & Yield% : 0.15 |
EPS(TTM) : 57.32 |
|
Book Value(₹) : 814.02 |
Market Cap(₹Cr) : 46,593.50 |
Face Value(₹) : 1.00 |
| Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 28.22 | 28.22 | 28.22 | 28.22 | 28.22 |
| Reserves | 22,942.40 | 17,849.25 | 16,710.37 | 14,781.29 | 13,198.05 |
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Shareholders Funds | 22,970.62 | 17,877.47 | 16,738.59 | 14,809.51 | 13,226.27 |
| Secured Loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured Loans | 707.29 | 3,221.22 | 3,737.70 | 3,703.99 | 3,573.76 |
| Total Debt | 707.29 | 3,221.22 | 3,737.70 | 3,703.99 | 3,573.76 |
| Other Liabilities | 131.94 | 372.58 | 121.32 | 136.61 | 205.65 |
| Total Liabilities | 23,809.85 | 21,471.27 | 20,597.61 | 18,650.11 | 17,005.68 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 3,392.75 | 3,183.65 | 3,026.28 | 2,848.56 | 2,595.06 |
| Less: Accumulated Depreciation | 1,636.50 | 1,437.70 | 1,273.95 | 1,126.07 | 983.11 |
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Block | 1,756.25 | 1,745.95 | 1,752.33 | 1,722.49 | 1,611.95 |
| Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Work in Progress | 197.67 | 172.34 | 109.04 | 131.40 | 200.01 |
| Investments | 12,964.79 | 10,332.71 | 8,559.39 | 6,989.95 | 4,713.93 |
| Current Assets, Loans & Advances | |||||
| Inventories | 1,142.69 | 1,090.21 | 951.66 | 762.39 | 837.50 |
| Sundry Debtors | 2,484.47 | 2,505.66 | 2,678.32 | 2,488.75 | 1,835.24 |
| Cash and Bank Balance | 129.15 | 93.79 | 29.63 | 15.79 | 88.26 |
| Loans and Advances | 925.17 | 696.82 | 743.31 | 1,642.20 | 1,662.89 |
| Total Current Assets | 4,681.48 | 4,386.48 | 4,402.93 | 4,909.12 | 4,423.89 |
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 3,249.79 | 2,952.14 | 2,168.39 | 1,834.31 | 1,827.48 |
| Provisions | 354.74 | 162.52 | 148.49 | 133.11 | 118.45 |
| Total CL & Provisions | 3,604.54 | 3,114.66 | 2,316.88 | 1,967.41 | 1,945.92 |
| Net Current Assets | 1,076.94 | 1,271.82 | 2,086.05 | 2,941.71 | 2,477.97 |
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Assets | 475.61 | 1,160.25 | 1,137.47 | 1,118.72 | 1,081.34 |
| Deferred Tax Liability | 309.77 | 213.50 | 214.20 | 265.43 | 276.60 |
| Net Deferred Tax | 165.84 | 946.75 | 923.27 | 853.29 | 804.74 |
| Other Assets | 7,648.37 | 7,001.70 | 7,167.54 | 6,011.27 | 7,197.08 |
| Total Assets | 23,809.85 | 21,471.26 | 20,597.62 | 18,650.11 | 17,005.68 |
| Contingent Liabilities | 2,658.49 | 3,443.30 | 3,325.06 | 3,730.17 | 4,430.59 |